199 related articles for article (PubMed ID: 35235807)
1. Epitope length variants balance protective immune responses and viral escape in HIV-1 infection.
Pymm P; Tenzer S; Wee E; Weimershaus M; Burgevin A; Kollnberger S; Gerstoft J; Josephs TM; Ladell K; McLaren JE; Appay V; Price DA; Fugger L; Bell JI; Schild H; van Endert P; Harkiolaki M; Iversen AKN
Cell Rep; 2022 Mar; 38(9):110449. PubMed ID: 35235807
[TBL] [Abstract][Full Text] [Related]
2. Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules.
Fadda L; O'Connor GM; Kumar S; Piechocka-Trocha A; Gardiner CM; Carrington M; McVicar DW; Altfeld M
J Virol; 2011 Jun; 85(12):5970-4. PubMed ID: 21471246
[TBL] [Abstract][Full Text] [Related]
3. CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
Cardinaud S; Consiglieri G; Bouziat R; Urrutia A; Graff-Dubois S; Fourati S; Malet I; Guergnon J; Guihot A; Katlama C; Autran B; van Endert P; Lemonnier FA; Appay V; Schwartz O; Kloetzel PM; Moris A
PLoS Pathog; 2011 May; 7(5):e1002049. PubMed ID: 21589903
[TBL] [Abstract][Full Text] [Related]
4. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
Brander C; Yang OO; Jones NG; Lee Y; Goulder P; Johnson RP; Trocha A; Colbert D; Hay C; Buchbinder S; Bergmann CC; Zweerink HJ; Wolinsky S; Blattner WA; Kalams SA; Walker BD
J Virol; 1999 Dec; 73(12):10191-8. PubMed ID: 10559335
[TBL] [Abstract][Full Text] [Related]
5. HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome.
Ammaranond P; van Bockel DJ; Petoumenos K; McMurchie M; Finlayson R; Middleton MG; Davenport MP; Venturi V; Suzuki K; Gelgor L; Kaldor JM; Cooper DA; Kelleher AD
J Immunol; 2011 Jan; 186(1):479-88. PubMed ID: 21115730
[TBL] [Abstract][Full Text] [Related]
6. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
[TBL] [Abstract][Full Text] [Related]
7. Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8
Karimzadeh H; Kiraithe MM; Kosinska AD; Glaser M; Fiedler M; Oberhardt V; Salimi Alizei E; Hofmann M; Mok JY; Nguyen M; van Esch WJE; Budeus B; Grabowski J; Homs M; Olivero A; Keyvani H; Rodríguez-Frías F; Tabernero D; Buti M; Heinold A; Alavian SM; Bauer T; Schulze Zur Wiesch J; Raziorrouh B; Hoffmann D; Smedile A; Rizzetto M; Wedemeyer H; Timm J; Antes I; Neumann-Haefelin C; Protzer U; Roggendorf M
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669837
[TBL] [Abstract][Full Text] [Related]
8. Switching and emergence of CTL epitopes in HIV-1 infection.
Han C; Kawana-Tachikawa A; Shimizu A; Zhu D; Nakamura H; Adachi E; Kikuchi T; Koga M; Koibuchi T; Gao GF; Sato Y; Yamagata A; Martin E; Fukai S; Brumme ZL; Iwamoto A
Retrovirology; 2014 May; 11():38. PubMed ID: 24886641
[TBL] [Abstract][Full Text] [Related]
9. CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 Nef.
Milicic A; Price DA; Zimbwa P; Booth BL; Brown HL; Easterbrook PJ; Olsen K; Robinson N; Gileadi U; Sewell AK; Cerundolo V; Phillips RE
J Immunol; 2005 Oct; 175(7):4618-26. PubMed ID: 16177107
[TBL] [Abstract][Full Text] [Related]
10. Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells.
Payne RP; Kløverpris H; Sacha JB; Brumme Z; Brumme C; Buus S; Sims S; Hickling S; Riddell L; Chen F; Luzzi G; Edwards A; Phillips R; Prado JG; Goulder PJ
J Virol; 2010 Oct; 84(20):10543-57. PubMed ID: 20686036
[TBL] [Abstract][Full Text] [Related]
11. An early HIV mutation within an HLA-B*57-restricted T cell epitope abrogates binding to the killer inhibitory receptor 3DL1.
Brackenridge S; Evans EJ; Toebes M; Goonetilleke N; Liu MK; di Gleria K; Schumacher TN; Davis SJ; McMichael AJ; Gillespie GM
J Virol; 2011 Jun; 85(11):5415-22. PubMed ID: 21430058
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid.
Schneidewind A; Brockman MA; Sidney J; Wang YE; Chen H; Suscovich TJ; Li B; Adam RI; Allgaier RL; Mothé BR; Kuntzen T; Oniangue-Ndza C; Trocha A; Yu XG; Brander C; Sette A; Walker BD; Allen TM
J Virol; 2008 Jun; 82(11):5594-605. PubMed ID: 18385228
[TBL] [Abstract][Full Text] [Related]
13. Variable HIV peptide stability in human cytosol is critical to epitope presentation and immune escape.
Lazaro E; Kadie C; Stamegna P; Zhang SC; Gourdain P; Lai NY; Zhang M; Martinez SA; Heckerman D; Le Gall S
J Clin Invest; 2011 Jun; 121(6):2480-92. PubMed ID: 21555856
[TBL] [Abstract][Full Text] [Related]
14. Precise identification of a human immunodeficiency virus type 1 antigen processing mutant.
Zimbwa P; Milicic A; Frater J; Scriba TJ; Willis A; Goulder PJ; Pillay T; Gunthard H; Weber JN; Zhang HT; Phillips RE
J Virol; 2007 Feb; 81(4):2031-8. PubMed ID: 17108020
[TBL] [Abstract][Full Text] [Related]
15. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection.
Brumme ZL; Brumme CJ; Carlson J; Streeck H; John M; Eichbaum Q; Block BL; Baker B; Kadie C; Markowitz M; Jessen H; Kelleher AD; Rosenberg E; Kaldor J; Yuki Y; Carrington M; Allen TM; Mallal S; Altfeld M; Heckerman D; Walker BD
J Virol; 2008 Sep; 82(18):9216-27. PubMed ID: 18614631
[TBL] [Abstract][Full Text] [Related]
16. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
[TBL] [Abstract][Full Text] [Related]
17. The flexibility of the TCR allows recognition of a large set of naturally occurring epitope variants by HIV-specific cytotoxic T lymphocytes.
Buseyne F; Rivière Y
Int Immunol; 2001 Jul; 13(7):941-50. PubMed ID: 11431424
[TBL] [Abstract][Full Text] [Related]
18. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
[TBL] [Abstract][Full Text] [Related]
19. HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in Nef and Gag proteins.
Chakraborty S; Rahman T; Chakravorty R; Kuchta A; Rabby A; Sahiuzzaman M
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):270-8. PubMed ID: 23061377
[TBL] [Abstract][Full Text] [Related]
20. Viral evolution in HLA-B27-restricted CTL epitopes in human immunodeficiency virus type 1-infected individuals.
Setiawan LC; Gijsbers EF; van Nuenen AC; Kootstra NA
J Gen Virol; 2015 Aug; 96(8):2372-2380. PubMed ID: 25872744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
